Sarepta Therapeutics (SRPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SRPT | TECH | EXAS | ||
| Company | Sarepta Therapeutics | Bio-Techne Corp | Exact Sciences Cor | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 119.59 | 71.25 | 56.04 | ||
| High | 121.00 | 74.27 | 59.70 | ||
| Low | 118.56 | 71.25 | 55.98 | ||
| Last | 118.97 | 73.17 | 59.40 | ||
| Change | -0.50 | +1.78 | +3.29 | ||
| % Change | -0.42% | +2.49% | +5.86% | ||
| Volume | 1,952,900 | 2,221,100 | 3,273,800 | ||
| 20-Day Average Volume | 1,081,915 | 795,410 | 2,282,270 | ||
| Previous Close | 119.47 | 71.39 | 56.11 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 125.31 | 74.89 | 60.38 | ||
| 20-Day Raw Stochastic | 29.92% | 41.28% | 55.18% | ||
| 20-Day Relative Strength | 45.30% | 48.14% | 48.22% | ||
| Weighted Alpha | +1.64 | -4.97 | -9.67 | ||
| Today's Opinion | 72% Sell | 24% Sell | 8% Sell | ||
| Previous Opinion | 72% Sell | 24% Sell | 40% Sell | ||
| Last Month's Opinion | 88% Sell | 72% Sell | 8% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.83% since 12/13/24 | -3.33% since 12/13/24 | -3.02% since 12/13/24 | ||
| Low | 117.97 on 12/19/24 | 69.48 on 12/19/24 | 55.65 on 12/19/24 | ||
| High | 128.73 on 12/16/24 | 77.62 on 12/17/24 | 62.15 on 12/17/24 | ||
| 1-Month | |||||
| %Chg | +7.32% since 11/20/24 | +6.48% since 11/20/24 | +12.71% since 11/20/24 | ||
| Low | 109.03 on 11/21/24 | 68.42 on 11/21/24 | 52.17 on 11/21/24 | ||
| High | 138.81 on 11/29/24 | 78.42 on 12/11/24 | 64.77 on 12/05/24 | ||
| 3-Month | |||||
| %Chg | -6.48% since 09/20/24 | -6.55% since 09/20/24 | -15.25% since 09/20/24 | ||
| Low | 102.15 on 11/18/24 | 65.61 on 11/20/24 | 48.02 on 11/12/24 | ||
| High | 138.81 on 11/29/24 | 80.80 on 11/06/24 | 72.83 on 11/05/24 | ||
| 6-Month | |||||
| %Chg | -3.67% since 06/20/24 | -1.82% since 06/20/24 | +35.00% since 06/20/24 | ||
| Low | 102.15 on 11/18/24 | 65.61 on 11/20/24 | 40.62 on 06/25/24 | ||
| High | 173.25 on 06/21/24 | 83.62 on 07/31/24 | 72.83 on 11/05/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 11,364,014 | 11,626,126 | 10,993,515 | ||
| Shares Outstanding, K | 95,520 | 158,892 | 185,076 | ||
| Annual Sales | 1,243,340,000 | 1,159,060,000 | 2,499,770,000 | ||
| Annual Net Income | -535,980,000 | 168,110,000 | -204,150,000 | ||
| Last Quarter Sales | 467,170,000 | 289,460,000 | 708,660,000 | ||
| Last Quarter Net Income | 33,610,000 | 33,600,000 | -38,240,000 | ||
| 60-Month Beta | 0.77 | 1.27 | 1.24 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.62 on 11/06/24 | 0.42 on 10/30/24 | -0.21 on 11/05/24 | ||
| Latest Earnings Date | 11/06/24 | 02/06/25 | 11/05/24 | ||
| Most Recent Dividend | N/A | 0.080 on 11/08/24 | N/A | ||
| Next Ex-Dividends Date | N/A | 11/08/24 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 102.56 | 44.89 | 0.00 | ||